Paper Details

  1. Home
  2. Paper Details

Melatonin as add-on treatment for epilepsy.

Author: BrigoFrancesco, Del FeliceAlessandra, IgweStanley C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This updated Cochrane review examined the use of melatonin as an antiepileptic medication. While many antiepileptic drugs (AEDs) are available, 30% of patients continue to have seizures. The study investigates melatonin's potential role as a better-tolerated AED, particularly for patients who do not respond well to conventional treatments.
Paper Details　
Original Abstract of the Article :
This is an updated version of the original Cochrane review published in Issue 6, 2012.Epilepsy is one of the most common chronic neurological disorders. Despite the plethora of antiepileptic drugs (AEDs) currently available, 30% of people continue having seizures. This group of people requires a mor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386917/

データ提供：米国国立医学図書館（NLM）

Melatonin: A New Oasis in the Epilepsy Desert

This research takes us into the fascinating realm of [epilepsy] where scientists are searching for new ways to combat this chronic neurological disorder. The current landscape of epilepsy treatment is riddled with challenges. While many antiepileptic drugs (AEDs) are available, a significant number of people continue to experience seizures. These individuals are like travelers lost in a vast desert, desperately seeking relief from the storms of epilepsy. This study explores the potential of melatonin as a new AED, offering hope for those struggling to control their seizures.

A Promising New Approach: Melatonin for Epilepsy

The researchers found that melatonin may offer a promising new treatment option for epilepsy, particularly for those who do not respond to conventional AEDs. Melatonin is like a gentle breeze, calming the stormy waters of epilepsy. The study suggests that melatonin has a good safety profile, making it a potentially valuable addition to the treatment arsenal. The researchers are hopeful that melatonin could offer a more tolerable alternative for individuals seeking relief from seizures.

Exploring New Pathways for Epilepsy Treatment

This study encourages further exploration of melatonin as a treatment for epilepsy. It highlights the need for research into alternative approaches to address the challenges of managing this complex condition. The authors emphasize the importance of finding new strategies that are both effective and tolerable, offering hope for those navigating the desert of epilepsy.

Dr.Camel's Conclusion

This study offers a glimmer of hope for those struggling with epilepsy. Melatonin may be a new oasis in the desert of epilepsy treatment, providing a potential alternative for those seeking relief from seizures. Further research is needed to fully explore the therapeutic potential of melatonin, but this study represents a promising step forward in the fight against this debilitating condition.
Date :
  1. Date Completed 2016-10-20
  2. Date Revised 2020-08-11
Further Info :

Pubmed ID

27513702

DOI: Digital Object Identifier

PMC7386917

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.